| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; Lin W.-C.; Ho I.-L.; HONG-CHIANG CHANG ; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. | PLoS ONE | 24 | 19 | |
| 2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; Lin W.-C.; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; KUO-HOW HUANG | PLoS ONE | 24 | 19 | |
| 2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; WEI-CHOU LIN ; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; Pu Y.-S.; Shi C.-S.; Huang K.-H. | PLoS ONE | 24 | 19 | |
| 2013 | 2-Methoxyestradiol Induces Mitotic Arrest, Apoptosis, and Synergistic Cytotoxicity with Arsenic Trioxide in Human Urothelial Carcinoma Cells | Kuo K.-L.; Lin W.-C.; Ho I.-L.; Chang H.-C.; Lee P.-Y.; Chung Y.-T.; Hsieh J.-T.; YEONG-SHIAU PU ; Shi C.-S.; Huang K.-H. | PLoS ONE | 24 | 19 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; HONG-CHIANG CHANG ; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN ; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal of Molecular Medicine | 1 | 1 | |
| 2019 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study | Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG ; Huang K.-H. | Cells | 11 | 12 | |
| 2019 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study | Kuo K.-L.; Liu S.-H.; Lin W.-C.; PO-MING CHOW ; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. | Cells | 11 | 12 | |
| 2019 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study | Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN ; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. | Cells | 11 | 12 | |
| 2019 | The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study | Kuo K.-L.; Liu S.-H.; Lin W.-C.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG | Cells | 11 | 11 | |
| 2016 | Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study | Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; HONG-CHIANG CHANG ; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; Huang K.-H. | Urology | 7 | 7 | |
| 2016 | Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study | Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; WEI-CHOU LIN ; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; Huang K.-H. | Urology | 7 | 7 | |
| 2016 | Epigallocatechin Gallate Attenuates Partial Bladder Outlet Obstruction-induced Bladder Injury via Suppression of Endoplasmic Reticulum Stress-related Apoptosis - In Vivo Study | Hsieh J.-T.; Kuo K.-L.; Liu S.-H.; Shi C.-S.; Chang H.-C.; Lin W.-C.; Chou C.-T.; Hsu C.-H.; Liao S.-M.; Wang Z.-H.; Li C.-C.; KUO-HOW HUANG | Urology | 7 | 7 | |
| 2019 | Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway | Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW ; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. | International Journal of Molecular Sciences | 9 | 11 | |
| 2019 | Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway | Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; HONG-CHIANG CHANG ; Huang K.-H. | International Journal of Molecular Sciences | 9 | 11 | |
